Telo Genomics Corp. announces that it has granted incentive stock options to various directors, officers, employees and consultants of the Company to purchase up to an aggregate of 2,100,000 common shares of the Company pursuant to the Company’s stock option plan.
November 28, 2019
· 1 min read